Zenith® LP Abdominal Aortic Aneurysm (AAA) Post-Market Registry

Cook Group Incorporated76 enrolled

Overview

A registry to collect additional prospective intra-operative and follow-up information on physician use of the CE-marked Zenith® Low Profile Abdominal Aortic Aneurysm (AAA) Endovascular Graft under routine clinical care.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Abdominal Aortic Aneurysm Aorto-iliac Aneurysm

Interventions

Zenith® Low Profile AAA Endovascular GraftDEVICE

Treatment of an abdominal aortic or aorto-iliac aneurysm with the CE-marked Zenith(R) Low Profile AAA Endovascular Graft.

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Patient is implanted with Zenith® Low Profile AAA Endovascular Graft Exclusion Criteria: * Patients for whom this device would not normally be considered standard of care.

Locations (15)

AKH (General Hospital Vienna)

Vienna, Austria

UHZ Hamburg GmbH (Eppendorf University Hospital)

Hamburg, Germany

Klinikum rechts der Isar (RDI Munich)

Munich, Germany

Outcomes

Primary Outcomes

graft patency and aneurysm exclusion

Time frame: during (day 1) and after implantation through 12 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.